Harrison M. Bains's most recent trade in Tvardi Therapeutics Inc. was a trade of 44,961 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 1, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tvardi Therapeutics Inc | Harrison M. Bains | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 44,961 | 44,961 | - | - | Stock Option (Right to Buy) | |
| Tvardi Therapeutics Inc | Harrison M. Bains | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 32,362 | 57,438 (0%) | 0% | 0 | Common Stock | |
| Tvardi Therapeutics Inc | Harrison M. Bains | Director | Sale of securities on an exchange or to another person at price $ 9.05 per share. | 15 Jul 2022 | 7,200 | 25,076 (0%) | 0% | 9.1 | 65,160 | Common Stock |
| Tvardi Therapeutics Inc | Harrison M. Bains | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 16,996 | 16,996 | - | - | Stock Option (Right to Buy) | |
| Tvardi Therapeutics Inc | Harrison M. Bains | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 11,876 | 32,276 (0%) | 0% | 0 | Common Stock | |
| Tvardi Therapeutics Inc | Harrison M. Bains | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 10,800 | 10,800 | - | - | Stock Option (Right to Buy) | |
| Tvardi Therapeutics Inc | Harrison M. Bains | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 7,200 | 20,400 (0%) | 0% | 0 | Common Stock |